Publications (28)

2023

  1. Current Treatments and New, Tentative Therapies for Parkinson’s Disease

    Pharmaceutics, Vol. 15, Núm. 3

  2. Poor Cognitive Agility Conservation in Obese Aging People

    Biomedicines, Vol. 11, Núm. 1

  3. Metabolic Disturbance of High-Saturated Fatty Acid Diet in Cognitive Preservation

    International Journal of Molecular Sciences, Vol. 24, Núm. 9

  4. Current Treatments and New, Tentative Therapies for Parkinson’s Disease

    Pharmaceutics, Vol. 15, Núm. 3, pp. 770

2022

  1. Therapeutic Approach to Alzheimer’s Disease: Current Treatments and New Perspectives

    Pharmaceutics, Vol. 14, Núm. 6

  2. Accelerated amyloid angiopathy and related vascular alterations in a mixed murine model of Alzheimer´s disease and type two diabetes

    Fluids and Barriers of the CNS, Vol. 19, Núm. 1

2021

  1. Current understanding of the physiopathology, diagnosis and therapeutic approach to alzheimer’s disease

    Biomedicines, Vol. 9, Núm. 12

2020

  1. Cell proliferation and neurogenesis alterations in Alzheimer’s disease and diabetes mellitus mixed murine models

    Journal of Neurochemistry, Vol. 154, Núm. 6, pp. 673-692

  2. Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer's mouse model

    Journal of Neuroinflammation, Vol. 17, Núm. 1

2019

  1. El cine como herramienta auxiliar en prácticas de Anatomía Humana

    Edunovatic 2018. Conference Proceedings: 3rd Virtual International Conference on Education, Innovation and ICT. 17-19 December, 2018

  2. Altered plasma-type gelsolin and amyloid-β in neonates with hypoxic-ischaemic encephalopathy under therapeutic hypothermia

    Journal of Cerebral Blood Flow and Metabolism, Vol. 39, Núm. 7, pp. 1349-1354

2018

  1. Cognitive Impairment and Brain and Peripheral Alterations in a Murine Model of Intraventricular Hemorrhage in the Preterm Newborn

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 4896-4910

  2. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer’s Disease and Type 2 Diabetes

    Molecular Neurobiology, Vol. 55, Núm. 7, pp. 6130-6144

2017

  1. Progressive Neuronal Pathology and Synaptic Loss Induced by Prediabetes and Type 2 Diabetes in a Mouse Model of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 54, Núm. 5, pp. 3428-3438

  2. Mango leaf extract improves central pathology and cognitive impairment in a type 2 diabetes mouse model

    Brain Pathology, Vol. 27, Núm. 4, pp. 499-507

  3. Long-Term Mangiferin Extract Treatment Improves Central Pathology and Cognitive Deficits in APP/PS1 Mice

    Molecular Neurobiology, Vol. 54, Núm. 6, pp. 4696-4704

  4. Intranasal insulin reverts central pathology and cognitive impairment in diabetic mother offspring

    Molecular Neurodegeneration, Vol. 12, Núm. 1

2016

  1. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes

    Psychoneuroendocrinology, Vol. 65, pp. 15-25

  2. Increased Spontaneous Central Bleeding and Cognition Impairment in APP/PS1 Mice with Poorly Controlled Diabetes Mellitus

    Molecular Neurobiology, Vol. 53, Núm. 4, pp. 2685-2697

  3. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease

    European Journal of Neuroscience, Vol. 44, Núm. 12, pp. 3056-3066